Jeff Thornton

(Charlottesville, VA) February 15, 2024 – Cerillo®, a technology company specializing in advanced research platforms for microbiome studies, is pleased to announce the addition of Jeff Thornton to its accomplished team as the Director of Sales.

Thornton joins Cerillo with a wealth of experience in sales management and business development within the life sciences sector, particularly in scientific instrumentation. 

Prior to his appointment at Cerillo, Thornton served as the Director of Sales at Cytena (BICO), where he played a pivotal role in expanding sales across North America. His impressive track record includes leadership positions at esteemed organizations such as Beckman Coulter Life Sciences, (Danaher), Tecan, and Biorad. 

Thornton arrives at Cerillo poised to spearhead strategic growth initiatives. In addition to his extensive sales background, Thornton holds a degree in biological sciences from the University of California, Santa Barbara, and has held roles in research and sales engineering.

“We are delighted to welcome Jeff as the newest member of the Cerillo team,” says Eric Mayton, CEO of Cerillo. “Jeff brings a unique blend of scientific expertise, industry knowledge, and strategic business development acumen, which will be instrumental in advancing Cerillo’s mission to provide cutting-edge research tools to scientists worldwide. With Jeff on board, we are poised for even greater success and impact in the field of microbiome research.”

About Cerillo
Cerillo is a technology company at the forefront of microbiome research and innovation with a mission to develop innovative solutions that enable in-depth exploration and analysis of the microbiome at the bench. The Company’s Microbiome Discovery Platform introduces unprecedented efficiencies, elevating data standardization, reproducibility, and analysis of research findings while addressing the challenges of variability in microbiome studies. Cerillo's commitment to democratizing microbiome engineering ensures accessibility, portability, scalability, and affordability, inviting researchers to gain a comprehensive understanding of biological systems, methods of action, and true causation in microbiome studies. www.cerillo.bio

Media Contact
Meghan O’Sullivan
meghan@cerillo.bio
 
Sales Contact
Mike Fitzpatrick
mike@cerillo.bio